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Background: The epigenetic plasticity hypothesis indicates that pregnancy exposure may result in adult-onset
diseases, including hypertension, diabetes and cardiovascular disease, in offspring. In a previous study, we discovered
that prenatal exposure to inflammatory stimulants, such as lipopolysaccharides (LPS), could lead to hypertension
in adult rat offspring. In the present study, we further demonstrate that maternal inflammation induces cardiac
hypertrophy and dysfunction via ectopic over-expression of nuclear transcription factor κB (NF- κB), and pyrrolidine
dithiocarbamate (PDTC) can protect cardiac function by reducing maternal inflammation.
Methods: Pregnant SD rats were randomly divided into three groups and intraperitoneally injected with a vehicle, LPS
(0.79 mg/kg), or LPS (0.79 mg/kg) plus PDTC (100 mg/kg) at 8 to 12 days of gestation. The offspring were raised until 4
and 8 months old, at which point an echocardiographic study was performed. The left ventricular (LV) mass index and
apoptosis were examined.
Results: At 4 months of age, the LPS offspring exhibited augmented posterior wall thickness. These rats displayed left
ventricle (LV) hypertrophy and LV diastolic dysfunction as well as a higher apoptotic index, a higher level of Bax and a
lower level of Bcl-2 at 8 months of age. The protein levels of NF-κB (p65) in the myocardium of the offspring were
measured at this time. NF-κB protein levels were higher in the myocardium of LPS offspring. The offspring that were
prenatally treated with PDTC displayed improved signs of blood pressure (BP) and LV hypertrophy.
Conclusions: Maternal inflammation can induce cardiac hypertrophy in offspring during aging accompanied with
hypertension emergence and can be rescued by the maternal administration of PDTC (the inhibitor of NF-κB).
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Immunological and inflammatory responses are believed
to play major roles in the pathophysiology of cardiovas-
cular disease (CVD). However, the detailed mechanism
is not yet clear. Myocardial remodelling, the major risk
factor underlying cardiovascular morbidity and mortal-
ity, is commonly observed in individuals with essential
hypertension. Myocardial remodelling is primarily a dis-
ease of the elderly [1]. It involves a continuum of
changes in the structure and function of the myocar-
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reproduction in any medium, provided the orand heart failure (HF) as a result of pathological pro-
cesses [2]. Chronic hypertension, congenital heart dis-
ease with intracardiac shunting, and cardiac valvular
disease may also lead to heart remodelling [3,4]. How-
ever, we identified a new agent in addition to common
injury that could result in myocardial remodelling. This
agent is developmental programming that may be af-
fected by maternal inflammation. It would be valuable to
investigate the adverse events of this agent during early
life and adult-onset diseases.
The perturbations during gestation and neonatal life
can influence long-term metabolic homeostasis factors,
such as weight, food intake, serum lipids, and insulin
resistance [5]. Elevated blood pressure in offspring has
also been studied, which may be triggered by the antenatal ad-
ministration of glucocorticoids, hypoxia, impaired placental. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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modifications of nutritional regimens [6]. Systemic inflam-
matory response during pregnancy also represents one
type of stressful event that can affect the foetus, and its
effects on developmental programming are not clear [7].
Recently, we have found that prenatal exposure to lipo-
polysaccharide (LPS), which is commonly used to mimic
prenatal infection, could result in increased TNF-α and
IL-6 levels in pregnant rats and induce hypertension in
adult offspring [8]. These effects indicate that maternal in-
flammation has effects on foetal developmental program-
ming that could induce offspring adulthood disease.
Furthermore, maternal immunological and inflammatory
responses may have long-term effects on tissue struc-
tures and functions in offspring, with the heart and
blood vessels being particularly affected. Therefore, in
this study, we investigated how cardiac function and
structure are influenced by maternal inflammation.
Lipopolysaccharides are the major constituents of the
outer membrane of Gram-negative bacteria. They act as
endotoxins, which are nonspecific immunostimulants, to
mimic the bacterial inflammatory response [9]. LPS initi-
ates a series of phosphorylation events by binding to
Toll-like receptor 4 (TLR4) and promoting the trans-
location of the nuclear transcription factor (NF)-κB into
the nucleus [10]. NF-κB is a major mediator of LPS sig-
nalling and is a central regulator in immunological and
inflammatory processes [11,12]. Pyrrolidine dithiocarba-
mate (PDTC) is a pharmacological inhibitor of NF-κB
[13]. Various studies have shown that PDTC can prevent
hypertension in spontaneously hypertensive rats and ex-
cessive ECM deposition in maladaptive cardiac remodel-
ling during HF in rats [13,14].
In this study, we determined that prenatal exposure to
inflammatory stimulants could result in myocardial re-
modelling with hypertension in adult offspring due to
ectopic over-expression of NF-κB, and we uncovered the
therapeutic benefits of maternal PDTC treatment in car-




This study was conducted in accordance with the Guide
for the Care and Use of Laboratory Animals published
by the US National Institutes of Health (NIH Publication
No. 85–23, revised 1996) and was approved by the local
animal ethics committee at the Third Military Medical
University. Animals that were previously reported to be-
come hypertensive after prenatal treatment with LPS
early in gestation were used in this study [8]. Briefly,
female and male Sprague Dawley (SD) rats that were
purchased from the Animal Center of the Third Military
Medical University (Chongqing, China) were mated (onefemale to one male; mating was confirmed based on the
analysis of the vaginal plug and vaginal smear).
Dams and litters
Throughout pregnancy, the rats were housed in standard
rat cages with ad libitum access to water and food
(standard lab rat chow). One week after they were accli-
matised in our institute, the dams were randomly di-
vided into the 3 following groups (n = 8 in each group):
the control group, the LPS group and the LPS + PDTC
group. The pregnant rats in the control group were in-
traperitoneally (i.p.) administered the vehicle daily from
days 8 to 14 of gestation. In the LPS group, the rats were
administered i.p. 0.79 mg/kg LPS (Escherichia coli 026:
B6, Sigma, St. Louis, MO, USA) on days 8, 10 and 12.
The rats in the LPS + PDTC group were administered
i.p. 0.79 mg/kg LPS plus 100 mg/kg PDTC (Sigma
Chemical) on days 8, 10 and 12. Gestation lasted for
20–22 d. All offspring rats from the same group were
mixed together; they were redistributed within the same
group so that there were 4 male and 4 female offspring
rats per lactating mother. In each group, one lactating
mother received the remaining litters after redistributed
no matter how many offspring rats were left. The rats
were left undisturbed until they reached 4 weeks of age,
when they were weaned. At that time, all of the offspring
rats from the same group were mixed together and were
randomly allocated into cages. The offspring rats lived
for 4 or 8 months until they were considered to be
young adults and aged adults, respectively. Both male
and female offspring rats were studied, and there were
no gender differences in the current study.
Blood pressure measurement
Systolic blood pressure (SBP) was measured in six con-
scious offspring rats from each group at 2, 4, 6 and
8 months of age using the standard tail-cuff method
(ML125; Powerlab, ADInstruments, Castle Hill, NSW,
Australia) [7]. The rats were initially trained to adapt to
the method before the valid measurements were taken
at least three times. Before SBP measurements, the rats
were placed inside a warming chamber (approximately
34°C) for 15 min and were then placed in plastic re-
straints. A cuff with a pneumatic pulse sensor was at-
tached to the tail. For each rat, the mean SBP was
calculated from three consecutive recordings. The mean
of all of the obtained values was used in the calculations.
Echocardiographic evaluation
High-resolution echocardiography has been shown to be
an effective tool for the in vivo study of cardiovascular
function and structure in small rodents [15,16]. At 4
or 8 months of age, transthoracic echocardiography
was performed on the offspring rats after they were
Figure 1 Prenatal exposure to LPS influences SBP in rat
offspring. Pregnant rats were randomly divided into three groups
(n = 8 in each group): control, LPS and LPS + PDTC. SBP in the
offspring was measured using the standard tail-cuff method. **P < 0.05
compared with the controls; ##P < 0.05 compared with the offspring of
the LPS-treated rats. There was no significant difference between the
control group and the LPS + PDTC group (one-way analysis of variance).
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[17-19]. The chest of each rat was shaved, and a layer of
acoustic-coupling gel was applied to the thorax. Two-
dimensional (2D) echocardiography was performed using
a commercially available 12-MHz linear-array trans-
ducer system (IE33-S12-MHz; Philips, Hamburg, Germany).
The rats were placed in the left lateral decubitus pos-
ition. M-mode recordings of the LV were obtained at
the level of the mitral valve in the parasternal view using
2D echocardiographic guidance in both the short- and
long-axis views. Pulsed-wave Doppler was used to
examine the mitral diastolic inflow from the apical four-
chamber view. The 2D echocardiographic measure-
ments included the LV end-systolic and end-diastolic
diameters (LVESD and LVEDD, respectively), end-
diastolic LV posterior wall thickness (PWT), thickness
of the interventricular septum (IVST), ejection fraction
(EF) and fractional shortening (FS). FS was calculated as
(LVEDD–LVESD)/LVEDD. All of the measurements
were made in a blinded fashion from digital images that
were captured using analysis software that was installed
on the echocardiographic machine. For each measure-
ment, the data from three consecutive cardiac cycles
were averaged. The 2D and Doppler images were ob-
tained at a speed of 100 mm/s.
The diameters of the aortic root and left atrium were
obtained using M-mode with the scan head on the long-
axis and the beam parallel to the axis of the aortic valve.
The LV systolic function was evaluated by estimating the
EF, shortening fraction and cardiac output from the im-
ages that were obtained in M-mode of the LV short-axis.
The ventricular diastolic function was assessed by de-
scribing the transmitted Doppler signal. The E and A
wave velocities and gradients were measured in a modi-
fied parasternal long-axis with the beam placed on the
tip of the mitral leaflet. The E/A index, mitral deceler-
ation time, and myocardial performance index (Tei index)
were calculated [20].
Left ventricular hypertrophy index
After echocardiography, the rats were sacrificed by decapi-
tation, and the chest cavity was opened immediately. The
hearts were excised rapidly and placed into ice-cold saline
to remove the blood. The hearts then were weighed. The
atria were removed from the harvested hearts, and the left
ventricles were separated. The interventricular septum
remained as a part of the left ventricle [21,22]. The heart
index (HI) and LV mass index (LVMI) were calculated
as the ratio of heart weight (in mg) and LV wet weight
(in mg) to body weight (in g), respectively.
Histological examination
The LV tissue was sliced into 3-mm sections, which were
fixed in 10% neutral-buffered formalin. The tissues wereembedded in paraffin, sectioned at 5 μm and stained with
hematoxylin-eosin (HE). All of the slices were assessed
using a computer-assisted colour image analysis system
(Motic Images Advanced 3.0, GENEQ, Montreal, Canada).
The transverse diameter (TDM) and cross-sectional area
(CSA) of the cardiac myocytes were determined in the
HE-stained slices. For the measurement of the single-
cardiomyocyte cross-sectional area and width, a total of
30 left ventricular myocytes were sectioned transversely at
the level of the nucleus and randomly chosen from each
section at 400× magnification and traced.
Preparation of nuclear protein extract and western blot
analysis
At 8 months of age, six offspring rats from each group
were anaesthetised with pentobarbital i.p. and decapi-
tated. The hearts were removed immediately and placed
in ice-cold NaCl/Pi before they were cut into pieces.
The nuclear protein extracts were prepared according to
the instructions that were provided with the NE-PER
Nuclear and Cytoplasmic Extraction Reagents kit (Pierce
Biotechnology, Rockford, IL, USA). Following protein
quantification, the nuclear proteins (50 μg) were electropho-
resed on a 10% sodium dodecyl sulphate–polyacrylamide
gel, transferred to nitrocellulose, immunoblotted with an
anti-NF-κB (p65) antibody (1:1000 dilution; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), according to the
manufacturer’s instructions, and visualised with peroxidase
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Pierce Biotechnology Inc., Rockford, IL, USA).
Measurement of myocyte apoptosis by TUNEL assay
The apoptotic cardiac cells were identified using the ter-
minal deoxynucleotidyl transferase-mediated dUTP nick
end labelling (TUNEL) assay in 5-μm thick, formalin-fixed,
paraffin-embedded sections [23,24]. The rat myocardial tis-
sue sections were obtained from the 3 groups of offspring
at 8 months of age. The TUNEL assay (Roche, Germany)
was performed according to the manufacturer’s protocol
and counterstained with DAPI to mark all nuclei. The slides
were examined microscopically at 400× magnification.
Under fluorescent light with 490 nm, TUNEL-positive cells
were counted per 106 cardiomyocyte nuclei. The apoptotic
index was calculated as the number of apoptotic cardio-
myocyte nuclei per total cardiomyocyte nuclei.
Western blotting
The LV were removed at the end of the experiment, and
they were lysed with lysis buffer. After sonication, the
lysates were centrifuged, and the proteins were separated
by electrophoresis (SDS-PAGE (10–14%)) and transferred
onto a polyvinylidene difluoride (PVDF)-plus membrane.Table 1 Comparison of LV remodelling and function before (4
Age (4 months)
Control LPS
HR (bpm) 336 ± 12 340 ± 27
LVEDD (mm) 7.47 ± 0.25 7.78 ± 0.30
LVESD (mm) 4.11 ± 0.22 3.81 ± 0.12
PWT (mm) 2.02 ± 0.15 2.49 ± 0.23*
IVST (mm) 1.88 ± 0.18 1.66 ± 0.27
Mitral E maximum
vel. (mm/s) 1130 ± 46 1267 ± 192
Mitral A maximum
vel. (mm/s) 691 ± 17 693 ± 46
Mitral E/A index 1.63 ± 0.05 1.83 ± 0.23
Mitral deceleration time (ms) 48.65 ± 2.97 44.67 ± 6.28
Myocardial performance (Tei) index 0.35 ± 0.02 0.42 ± 0.03
Parasternal short-axis
FS (%) 45 ± 4.7 51 ± 1.6
EF (%) 75 ± 5.2 80 ± 4.7
Parasternal long-axis apical
Ao end-systolic diameter (mm) 3.54 ± 0.28 3.40 ± 0.66
Vp (cm/s) 1322 ± 88.6 1233 ± 109.1
VTI (mmHg) 8.22 ± 0.15 8.53 ± 0.32
A summary of the most relevant cardiac measurements that were obtained at 4 an
LVEDD, LV end-diastolic diameters; LVESD, LV end-systolic diameters; PWT, End-diast
septum; Ao, Aorta; vel, velocity; EF, LV ejection fraction; FS, LV fractional shortening;
The data are presented as the mean ± SEM (n = 6 in each group). *P < 0.05 vs. contThey were probed with a rat polyclonal Bax antibody
(sc-483, 1:500, Santa Cruz Biotechnology Inc., CA, USA)
and a mouse monoclonal Bcl-2 antibody (sc-7382, 1:500,
Santa Cruz Biotechnology Inc., CA, USA). The peroxidase
activity was detected using the Pierce ECL Western Blot-
ting Substrate. For the densitometric analysis, the immuno-
reactive bands were scanned with a Luminescent Imaging
Analyzer (LAS-4000, Fuji, Japan) and were quantified using
the Multi Gauge software (Fuji, Japan). A monoclonal anti-
body against β-actin (sc-47778, 1:1000, Santa Cruz Biotech-
nology Inc., CA, USA) was used as an internal control.
Statistics
All of the data are expressed as the mean ± SEM and
were analysed using the SPSS 16.0 software package
(SPSS, Chicago, IL, USA). Comparisons between the
groups were made using a one-way ANOVA with Fisher’s
least significant difference (LSD) post hoc test. P < 0.05
was considered to be statistically significant.
Results
Mother rats and offspring rats
There was no significant difference in the mean number
of progeny rats among the 3 groups. Additionally, themonths) and after (8 months) hypertension
Age (8 months)
LPS + PDTC Control LPS LPS + PDTC
338 ± 36 308 ± 5 302 ± 7 306 ± 9
7.44 ± 0.28 7.83 ± 0.36 7.94 ± 0.56 7.79 ± 0.35
4.08 ± 0.29 4.27 ± 0.30 3.78 ± 0.28* 4.13 ± 0.15#
1.99 ± 0.11# 2.42 ± 0.07 2.57 ± 0.10* 2.45 ± 0.27#
1.81 ± 0.17 2.01 ± 0.04 2.20 ± 0.10* 2.02 ± 0.03#
1283 ± 303 1281 ± 105 1305 ± 79 1291 ± 124
671 ± 31 908 ± 63 572 ± 43* 916 ± 57#
1.93 ± 0.54 1.41 ± 0.14 2.28 ± 0.15* 1.41 ± 0.14#
49.45 ± 4.95 42.05 ± 3.80 32.12 ± 3.17* 41.43 ± 2.67#
0.39 ± 0.01 0.34 ± 0.02 0.48 ± 0.03* 0.34 ± 0.02#
45 ± 5.8 45 ± 5.1 48 ± 2.0 47 ± 4.3
74 ± 6.3 75 ± 5.4 78 ± 1.8 77 ± 4.4
3.56 ± 0.14 3.75 ± 0.12 3.91 ± 0.13 3.80 ± 0.12
1354 ± 154.6 1160 ± 117.1 1040 ± 180.3 1146 ± 101.3
8.35 ± 0.33 7.76 ± 0.54 7.88 ± 0.68 7.64 ± 0.59
d 8 months of age using echocardiography. HR, Heart rate; LV, Left ventricle;
olic LV posterior wall thickness; IVST, The thickness of the interventricular
Vp, Ao peak ejection vel.; and VTI, Ao outflow vel./time integral.
rol group; #P <0.05 vs. LPS group.
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the body weights of the newborn offspring rats showed
no differences among the 3 groups.
SBP in adult offspring
The SBP levels were significantly increased in the LPS
group compared with the control and LPS + PDTC
groups during 6 and 8 months of age. At 6 months of
age, SBP in the LPS-treated offspring rats reached the
standard level of hypertension. At 8 months of age, the
LPS group reached 138.85 ± 7.68 mmHg, which was sig-
nificantly higher compared with that in the control
(123.64 ± 4.68 mmHg) and LPS + PDTC (125.54 ±
3.54 mmHg) groups. There was no significant difference
between the control group and the LPS + PDTC group
(Figure 1).Figure 2 Effect of prenatal exposure to LPS on the heart/body weigh
weight ratio (A) and left ventricle (LV)/total heart weight (B) in the offsprin
controls; ##P <0.05 compared with the offspring of the LPS-treated rats. The
LPS + PDTC group (one-way analysis of variance).Effects of prenatal LPS exposure on left-ventricular
morphometry and function
There were no significant differences in the heart rates
between the three groups. As indicated in Table 1, at the
end of 4 months, the PWTs were significantly increased
in the adult offspring in the LPS-treated group com-
pared with those in the control and LPS + PDTC groups
(P < 0.05). However, there were no differences in the LV
systolic and diastolic functions among the three groups.
The 8-month-old offspring from both sexes of the LPS
group indicated echocardiographic signs of increased
PWT thickness and IVST and LV diastolic dysfunction,
which included a decreased mitral A-wave maximum
velocity, isovolumetric relaxation time, and deceleration
time of the mitral valve as well as increased E/A and Tei
indexes (Table 1). There were no significant differencest ratio and left ventricle (LV)/total heart weight. The heart/body
g from the LPS or LPS + PDTC groups. **P < 0.05 compared with the
re was no significant difference between the control group and the
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and the control group.
Effect of prenatal exposure to LPS on the LV hypertrophy
index of adult offspring
Compared with the control rats, the heart weight, LV
weight, HI and LVMI were markedly increased in the LPS-
treated group at the end of 8 months (P < 0.05). There were
no differences in the HI and LVMI among the three groups
at the end of 4 months. All of the indices significantly de-
creased in the LPS + PDTC-treated group compared with
those in the LPS-treated group (P < 0.05) (Figure 2A and B).
Histological examination
Using an optical microscope, we observed that the myofi-
brillae were aligned without disruption in the control rats,
and the morphology and structure of the nuclei and cells
were normal. In contrast, the cardiomyocytes were hyper-
plastic and hypertrophied in the LPS-treated group at the
end of 8 months. Following the treatment with LPS +
PDTC, the morphology of the myocardium improved sig-
nificantly (Figure 3). We also examined the cardiomyocyte
size in the left ventricle and observed an increase in the
cross-sectional myocyte area and width in the LPS-treated
rats compared with the control rats. This increase was sig-
nificantly prevented by treatment with the prenatal injec-
tion of PDTC.
Prenatal exposure to LPS increases the NF-κB (p65)
content in the myocardium
At 8 months of age, the rats were sacrificed, and nuclear
extracts were prepared from the heart to investigate NF-Figure 3 Effect of prenatal exposure to LPS on cardiac myocyte hype
typical myocardial structure in the various groups (hematoxylin-eosin stain;
area for a single cell. (C) Quantitative morphometric analysis of the cardiom
##P <0.05 compared with the offspring of the LPS-treated rats.κB (p65) expression by western blotting. As shown in
Figure 4A and B, the expression of p65 in the LPS-treated
group was significantly higher compared to that in the
control and LPS + PDTC groups. This result indicates that
prenatal exposure to inflammatory stimuli can activate the
NF-κB signalling cascade in offspring myocardium.
Apoptosis
Apoptotic cardiomyocytes were detected by TUNEL stain-
ing in the hearts. Apoptotic nuclei were stained brown.
The apoptotic index in the LPS-treated animals was sig-
nificantly increased compared with that in the control and
LPS + PDTC groups (Figure 5).
Myocardial expression of Bcl-2 and Bax
As shown in Figure 6, prenatal exposure to LPS decreased
the expression of the Bcl-2 protein and increased the ex-
pression of the Bax protein in the myocardium, which re-
sulted in a decrease of the Bcl-2/Bax ratio; this result
indicates that the prenatal exposure to LPS induced apop-
tosis in the offspring rats. Furthermore, the intraperitoneal
administration of PDTC prevented the decrease of the
Bcl-2/Bax ratio.
Discussion
A number of studies suggested that the development of
CVD may be related to early events in childhood
[25,26]. The study of the long-term effects of certain
prenatal insults on cardiac structure and function has
become increasingly relevant [27]. Previous studies have
shown that changes in the intrauterine environment
(e.g., the restriction of maternal protein and calories orrtrophy in adult offspring. (A) Photomicrographs showing the
400×). (B) Quantitative morphometric analysis of the cardiomyocyte
yocyte width for a single cell. **P < 0.05 compared with the controls;
Figure 4 The pictures (A) show the WB results of activation of
the (NF)-κB pathway in offspring from the control, LPS and LPS +
PDTC groups. The graphs (B) show the results of the densitometric
analysis. Similar results were obtained forix animals in each group.
The data are the mean ± SEM. **P < 0.05 compared with the controls;
##P < 0.05 compared with the offspring of the LPS-treated rats.
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trigger early programming, which results in the develop-
ment of type 2 diabetes mellitus, hypertension, dyslipi-
daemia and CVD in adult offspring [28-32]. In our
previous study, we found that prenatal exposure to LPS
could result in increases of blood pressure and body
weight in rats [7].
In the present study, we explored the effects of mater-
nal LPS exposure in rats during gestation and its conse-
quences for BP and myocardial remodelling in adult life.
The MSAP of the offspring in the LPS-treated group
started to increase beginning at 2 months of age. The
rats that were exposed prenatally to LPS gradually
developed hypertension at 6 months of age [33]. The
blood pressure eached 138.85 ± 7.68 mmHg at the end
of 8 months of age. A similar increase in the MSAP
was not observed in either the control or LPS + PDTC-
treated groups.
In the present study, we tried to analyse the presence of
different patterns of remodelling in the hearts of adult rats
that were prenatally exposed to LPS and to determine
their functional implications. In a clinical setting, patients
usually display different geometric patterns of myocardial
remodelling. Using the mass index and the LV relative
wall thickness as echocardiographic variables, the patientsare usually divided into four different geometric patterns:
normal (normal mass index and normal relative thick-
ness), concentric remodelling (normal mass index and
increased relative thickness), concentric hypertrophy (in-
creased mass index and increased relative thickness), and
eccentric hypertrophy (increased mass index and normal
relative thickness). The remodelling pattern is a predictor
of cardiovascular events [34]. In the present study, we
found that at the end of 4 months, when the rats were de-
fined as young adults, LPS offspring hearts showed in-
creased PWT thickness but normal mass index with
hypertension formation. Concentric remodelling fit this
pattern. At the end of 8 months and with blood pressure
raised in the LPS group, an increased mass index and
increased PWTand IVST thicknesses were observed. Con-
centric hypertrophy occurred in the LPS group. Further-
more, hyperplastic and hypertrophic cardiomyocytes
were also observed in the LPS-treated group. Systolic
function, which was determined by echocardiography,
was not changed among the groups. In contrast, the E/
A and Tei indexes in the LPS group were significantly
increased compared with that in the control and LPS +
PDTC groups, which indicates moderate diastolic dys-
function in the LPS group. In this study, it is clear that the
adult offspring developed cardiomyocyte hypertrophy with
hypertension. It is likely that the cardiac remodelling was
likely programmed by the adverse intrauterine environ-
ment that was caused by maternal inflammation. The
present findings suggested that body and cardiac
growth are influenced by prenatal inflammatory expos-
ure conditions. These relationships between organ size
and function underscore one of the basic biological
compensatory properties: the inherent ability to in-
crease or decrease mass (hypertrophy or atrophy) and
to alter tissue configuration in a manner that is directly
related to functional requirements. This study may
represent a novel agent that can induce myocardial re-
modelling, may might also be an influential factor that
contributes to increased CVD morbidity and mortality.
NF-κB is a key transcription factor that is involved in
the regulation of many genes; it especially regulates
inflammation-associated immediate-early genes, and it is
closely associated with cardiovascular diseases, such as
hypertension, atherosclerosis, ischaemia reperfusion injury
and heart failure [13]. When a cell is quiescent, NF-κB
(p65) is predominantly restricted to the cytoplasm. Upon
stimulation (for example, by cytokines or in response to
inflammation), NF-κB is activated and translocated from
the cytoplasm into the nucleus, where it initiates the gen-
etic transcription of factors, such as TNF-α and IL-6 [35].
Previous studies by us and others have demonstrated that
LPS can induce an inflammatory response to infectious
bacteria in a pregnant mother that could be abolished by
PDTC treatment [7,9]. In the current study, we further
Figure 5 TUNEL analysis in control, LPS and LPS + PDTC groups. (A) Nuclei are shown in blue after staining with DAPI. TUNEL-stained cells
show green fluorescence in cells with single-stranded DNA breaks. (B) The apoptotic index analysis of the cardiomyocytes in the heart. **P < 0.05
vs. control group; ##P < 0.05 vs. LPS group.
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diac structure and function could be counteracted by the
inhibition of the NF-κB cascade with PDTC. These results
indicate that an intense inflammatory response occurred
in pregnant rats following LPS exposure, and this response
could induce cardiovascular disease, such as myocardial
remodelling and hypertension. The NF-κB signalling path-
way is most likely involved in this programming. Further-
more, in 8-month-old offspring rats from the LPS-treated
group, NF-κB was primarily localised in the nucleus of
cardiomyocytes. This phenomenon indicates the highsensitivity of the LPS-treated group to environmental
stress compared with the control group. However,
PDTC could reverse the LPS-mediated LV hyperten-
sion and myocardial remodelling in adult offspring
rats by inhibiting the NF-κB pathway, which can drive
maternal inflammatory reactivity.
It is noteworthy, however, that the mechanisms of the
myocardial remodelling induced by maternal LPS exposure
remain unclear. The exact mechanisms that are responsible
for the maternal inflammation-induced myocardial remod-
elling in offspring also remain unclear. To investigate
A        
B
Figure 6 The pictures (A) show the results of WB results on
Bcl-2 and Bax. The graphs (B) show the quantitative analysis on the
Bcl-2/Bax ratio by western blotting. Lane 1 represents the control
tissue, lane 2 represents the LPS-treated tissue, and lane 3 represents
the LPS + PDTC-treated tissue. Each value represents the mean ±
SEM of six rats. **P < 0.05 vs. control group; ##P < 0.05 vs. LPS group.
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induced offspring myocardial hypertrophy, myocardial
apoptosis in offspring rats was evaluated in the present
study. Previous studies demonstrated that apoptosis is in-
volved in the cardiac remodelling and substantial loss of
cardiomyocytes in genetic hypertension [36] and in reno-
vascular hypertension [37]. Cardiomyocyte apoptosis en-
hances the cardiac remodelling of hypertensive rats and
affects the cardiac interstitium [38]. Cardiomyocyte apop-
tosis induced by prenatal exposure to LPS may cause myo-
cardial remodelling in the current study. Ventricular
cardiomyocytes are normally considered to be terminally
differentiated cells, and the capacity for cardiac repair by
cardiomyocyte regeneration may be significantly decreased
shortly after birth. The previous study demonstrated that
cardiomyocyte growth under physiological and patho-
logical conditions is believed to be restricted to cellular
hypertrophy [39]. However, a recent study suggested that
cardiomyocyte replication is a component of the cellular
processes of ventricular remodelling. The potential occur-
rence of cardiomyocyte hyperplasia under special stimuli
remains controversial. In the present study, the adult off-
spring rats from the LPS-exposed group showed myocar-
dial remodelling, which was identified based on muscular
and intramyocardial arterial components and the reductionof the cardiomyocyte nuclei profile number. We speculate
that prenatal LPS exposure impaired the proliferative cap-
acity of the cardiomyocytes in offspring rats.
In summary, the current study demonstrated that pre-
natal stress, such as exposure to a maternal inflamma-
tory condition, is a key determinant of the development
of myocardial remodelling, hypertension, and other dys-
functions in adult offspring. Furthermore, we believe
that the NF-κB cascade is an important pathway in ma-
ternal inflammation-induced myocardial remodelling in
offspring. Treatment processes that prevent maternal in-
flammatory responses would likely be useful in the pre-
vention of cardiovascular and metabolic diseases, such
as offspring myocardial remodelling and hypertension. A
novel theory regarding the aetiology of offspring myocar-
dial remodelling and hypertension may be derived from
a clear delineation that myocardial remodelling and
hypertension in adult offspring can result from pregnant
mothers that are subjected to inflammatory stress.
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